| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




From the * Department of Microbiology and Research
Laboratory "Microorganismes et Pathologie Humaine," Habib
Bourguiba Hospital, Sfax, Tunisia;
and the
Laboratory of Histology-Embryology and Biology of Reproduction, Medical
School, Sfax, Tunisia.
| Correspondence to: Dr R. Gdoura or Prof A. Hammami, Laboratory of Microbiology, Faculté de Médecine de Sfax, Avenue Magida Boulila, 3029, Sfax, Tunisia (e-mail: gdourar{at}yahoo.com) (Dr Gdoura) (e-mail: Adnene.hammami{at}rns.tn) (Prof Hammami). |
> 0.9) between the detection of Chlamydia
trachomatis, genital ureaplasmas, and Mycoplasma hominis in
semen and corresponding FVU specimens. Our findings also show a high
concordance (81.1%) and a good agreement (
= 0.79) between the
detection of Mycoplasma genitalium in both specimens. C
trachomatis, genital mycoplasmas, and genital ureaplasmas were found to
be widespread among infertile male patients in Tunisia, as shown by their
respective prevalences of 43.3%, 18.3%, and 14.4%. The mean values of seminal
volume, sperm concentration, sperm viability, sperm motility, sperm
morphology, and leukocyte count were not significantly related either to the
detection of C trachomatis DNA or to that of genital ureaplasma or
mycoplasma DNA in semen specimens. Using our in-house PCR, both semen and FVU
were found to be sensitive diagnostic specimens for the detection of C
trachomatis, ureaplasmas, and mycoplasmas. The FVU, a less invasive and
self-collected specimen, can serve as a marker for the presence of these
organisms in the genital tract and can be used as a reliable way of detecting
asymptomatic carriers of infection.
Key words: Male infertility, sperm quality
This article has been cited by other articles:
![]() |
L. E. Manhart, J. M. Broad, and M. R. Golden Mycoplasma genitalium: Should We Treat and How? Clinical Infectious Diseases, December 15, 2011; 53(suppl_3): S129 - S142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eley How to Detect Chlamydia trachomatis in Males? J Androl, January 1, 2011; 32(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Znazen, O. Frikha-Gargouri, L. Berrajah, S. Bellalouna, H. Hakim, N. Gueddana, and A. Hammami Sexually transmitted infections among female sex workers in Tunisia: high prevalence of Chlamydia trachomatis Sex Transm Inf, December 1, 2010; 86(7): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lanjouw, J. M. Ossewaarde, A. Stary, F. Boag, and W. I. van der Meijden 2010 European guideline for the management of Chlamydia trachomatis infections Int J STD AIDS, November 1, 2010; 21(11): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kokab, M. M. Akhondi, M. R. Sadeghi, M. H. Modarresi, M. Aarabi, R. Jennings, A. A. Pacey, and A. Eley Raised Inflammatory Markers in Semen From Men With Asymptomatic Chlamydial Infection J Androl, March 1, 2010; 31(2): 114 - 120. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |